Annual total expenses:
$10.11B+$1.23B(+13.80%)Summary
- As of today (May 29, 2025), REGN annual total expenses is $10.11 billion, with the most recent change of +$1.23 billion (+13.80%) on December 31, 2024.
- During the last 3 years, REGN annual total expenses has risen by +$3.03 billion (+42.86%).
- REGN annual total expenses is now at all-time high.
Performance
REGN Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$2.44B-$362.00M(-12.93%)Summary
- As of today (May 29, 2025), REGN quarterly total expenses is $2.44 billion, with the most recent change of -$362.00 million (-12.93%) on March 31, 2025.
- Over the past year, REGN quarterly total expenses has increased by +$43.40 million (+1.81%).
- REGN quarterly total expenses is now -12.93% below its all-time high of $2.80 billion, reached on December 31, 2024.
Performance
REGN Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
REGN Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.8% | +1.8% |
| 3 y3 years | +42.9% | +42.8% |
| 5 y5 years | +132.5% | +116.0% |
REGN Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.9% | -12.9% | +42.8% |
| 5 y | 5-year | at high | +132.5% | -12.9% | +116.0% |
| alltime | all time | at high | >+9999.0% | -12.9% | +785.5% |
REGN Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.44B(-12.9%) |
| Dec 2024 | $10.11B(+13.8%) | $2.80B(+10.1%) |
| Sep 2024 | - | $2.54B(+2.6%) |
| Jun 2024 | - | $2.48B(+3.5%) |
| Mar 2024 | - | $2.39B(-2.8%) |
| Dec 2023 | $8.88B(+23.8%) | $2.46B(+9.3%) |
| Sep 2023 | - | $2.25B(+5.1%) |
| Jun 2023 | - | $2.14B(-3.3%) |
| Mar 2023 | - | $2.22B(-2.3%) |
| Dec 2022 | $7.18B(+1.4%) | $2.27B(+32.4%) |
| Sep 2022 | - | $1.71B(-2.0%) |
| Jun 2022 | - | $1.75B(+2.4%) |
| Mar 2022 | - | $1.71B(-26.2%) |
| Dec 2021 | $7.08B(+43.8%) | $2.31B(+44.0%) |
| Sep 2021 | - | $1.61B(-10.4%) |
| Jun 2021 | - | $1.79B(+26.5%) |
| Mar 2021 | - | $1.42B(+12.7%) |
| Dec 2020 | $4.92B(+13.2%) | $1.26B(+1.2%) |
| Sep 2020 | - | $1.24B(-4.2%) |
| Jun 2020 | - | $1.30B(+14.8%) |
| Mar 2020 | - | $1.13B(-5.0%) |
| Dec 2019 | $4.35B(+66.5%) | $1.19B(+18.2%) |
| Sep 2019 | - | $1.01B(-20.4%) |
| Jun 2019 | - | $1.26B(+41.4%) |
| Mar 2019 | - | $892.60M(-351.1%) |
| Dec 2018 | $2.61B(-31.2%) | -$355.50M(-134.3%) |
| Sep 2018 | - | $1.04B(+5.2%) |
| Jun 2018 | - | $985.80M(+4.4%) |
| Mar 2018 | - | $944.30M(-9.5%) |
| Dec 2017 | $3.79B(+7.4%) | $1.04B(+10.9%) |
| Sep 2017 | - | $940.75M(+2.3%) |
| Jun 2017 | - | $919.80M(+3.5%) |
| Mar 2017 | - | $888.45M(+1.0%) |
| Dec 2016 | $3.53B(+23.8%) | $879.84M(+2.6%) |
| Sep 2016 | - | $857.32M(-6.9%) |
| Jun 2016 | - | $921.00M(+5.7%) |
| Mar 2016 | - | $871.54M(+0.5%) |
| Dec 2015 | $2.85B(+42.9%) | $867.00M(+16.4%) |
| Sep 2015 | - | $745.00M(+14.0%) |
| Jun 2015 | - | $653.76M(+11.6%) |
| Mar 2015 | - | $586.06M(-0.1%) |
| Dec 2014 | $2.00B(+46.6%) | $586.53M(+9.2%) |
| Sep 2014 | - | $537.32M(+22.8%) |
| Jun 2014 | - | $437.61M(+0.8%) |
| Mar 2014 | - | $434.18M(+4.5%) |
| Dec 2013 | $1.36B(+47.9%) | $415.32M(+15.3%) |
| Sep 2013 | - | $360.23M(+20.3%) |
| Jun 2013 | - | $299.54M(+4.5%) |
| Mar 2013 | - | $286.61M(+6.6%) |
| Dec 2012 | $920.76M(+41.4%) | $268.93M(+19.4%) |
| Sep 2012 | - | $225.32M(+3.9%) |
| Jun 2012 | - | $216.92M(+3.5%) |
| Mar 2012 | - | $209.59M(+24.5%) |
| Dec 2011 | $650.98M(+17.0%) | $168.38M(+4.4%) |
| Sep 2011 | - | $161.29M(-4.1%) |
| Jun 2011 | - | $168.13M(+9.8%) |
| Mar 2011 | - | $153.19M(+4.6%) |
| Dec 2010 | $556.55M(+22.8%) | $146.45M(+6.1%) |
| Sep 2010 | - | $138.07M(-1.1%) |
| Jun 2010 | - | $139.61M(+5.4%) |
| Mar 2010 | - | $132.41M(-2.8%) |
| Dec 2009 | $453.37M(+39.6%) | $136.21M(+14.7%) |
| Sep 2009 | - | $118.75M(+11.7%) |
| Jun 2009 | - | $106.30M(+15.4%) |
| Mar 2009 | - | $92.12M(+6.1%) |
| Dec 2008 | $324.71M | $86.86M(+1.6%) |
| Sep 2008 | - | $85.52M(+6.5%) |
| Jun 2008 | - | $80.27M(+11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $72.29M(-5.2%) |
| Dec 2007 | $239.48M(+40.0%) | $76.26M(+25.1%) |
| Sep 2007 | - | $60.98M(+15.5%) |
| Jun 2007 | - | $52.80M(+6.8%) |
| Mar 2007 | - | $49.44M(+12.8%) |
| Dec 2006 | $171.10M(-393.8%) | $43.83M(-0.1%) |
| Sep 2006 | - | $43.88M(+0.9%) |
| Jun 2006 | - | $43.51M(+9.1%) |
| Mar 2006 | - | $39.88M(-119.8%) |
| Dec 2005 | -$58.23M(-134.6%) | -$201.89M(-499.1%) |
| Sep 2005 | - | $50.58M(+4.2%) |
| Jun 2005 | - | $48.53M(+8.9%) |
| Mar 2005 | - | $44.55M(+3.3%) |
| Dec 2004 | $168.37M(+6.9%) | $43.12M(-6.3%) |
| Sep 2004 | - | $46.00M(+12.0%) |
| Jun 2004 | - | $41.06M(+7.5%) |
| Mar 2004 | - | $38.20M(-0.6%) |
| Dec 2003 | $157.49M(+9.4%) | $38.41M(-10.9%) |
| Sep 2003 | - | $43.09M(+15.0%) |
| Jun 2003 | - | $37.46M(-2.7%) |
| Mar 2003 | - | $38.52M(-2.6%) |
| Dec 2002 | $143.94M(+33.7%) | $39.54M(+2.1%) |
| Sep 2002 | - | $38.74M(+9.1%) |
| Jun 2002 | - | $35.52M(+17.9%) |
| Mar 2002 | - | $30.13M(-11.4%) |
| Dec 2001 | $107.66M(+27.3%) | $33.99M(+18.1%) |
| Sep 2001 | - | $28.77M(+20.6%) |
| Jun 2001 | - | $23.86M(+13.5%) |
| Mar 2001 | - | $21.02M(-27.3%) |
| Dec 2000 | $84.55M(+45.0%) | $28.93M(-5.1%) |
| Sep 2000 | - | $30.49M(+65.4%) |
| Jun 2000 | - | $18.43M(-2.9%) |
| Mar 2000 | - | $18.98M(+50.6%) |
| Dec 1999 | $58.30M(+14.8%) | $12.60M(-23.2%) |
| Sep 1999 | - | $16.40M(+14.7%) |
| Jun 1999 | - | $14.30M(-9.5%) |
| Mar 1999 | - | $15.80M(+16.2%) |
| Dec 1998 | $50.80M(+25.1%) | $13.60M(+3.0%) |
| Sep 1998 | - | $13.20M(+3.1%) |
| Jun 1998 | - | $12.80M(+12.3%) |
| Mar 1998 | - | $11.40M(+11.8%) |
| Dec 1997 | $40.60M(-1.9%) | $10.20M(+2.0%) |
| Sep 1997 | - | $10.00M(-2.9%) |
| Jun 1997 | - | $10.30M(0.0%) |
| Mar 1997 | - | $10.30M(-6.4%) |
| Dec 1996 | $41.40M(+18.3%) | $11.00M(+3.8%) |
| Sep 1996 | - | $10.60M(+7.1%) |
| Jun 1996 | - | $9.90M(0.0%) |
| Mar 1996 | - | $9.90M(+16.5%) |
| Dec 1995 | $35.00M(-33.2%) | $8.50M(-1.2%) |
| Sep 1995 | - | $8.60M(-3.4%) |
| Jun 1995 | - | $8.90M(-1.1%) |
| Mar 1995 | - | $9.00M(-29.7%) |
| Dec 1994 | $52.40M(+6.1%) | $12.80M(+1.6%) |
| Sep 1994 | - | $12.60M(-7.4%) |
| Jun 1994 | - | $13.60M(+1.5%) |
| Mar 1994 | - | $13.40M(-5.0%) |
| Dec 1993 | $49.40M(+65.8%) | $14.10M(+9.3%) |
| Sep 1993 | - | $12.90M(+16.2%) |
| Jun 1993 | - | $11.10M(-1.8%) |
| Mar 1993 | - | $11.30M(+34.5%) |
| Dec 1992 | $29.80M(+76.3%) | $8.40M(+5.0%) |
| Sep 1992 | - | $8.00M(+19.4%) |
| Jun 1992 | - | $6.70M(0.0%) |
| Mar 1992 | - | $6.70M(+17.5%) |
| Dec 1991 | $16.90M(+103.6%) | $5.70M(+29.5%) |
| Sep 1991 | - | $4.40M(+18.9%) |
| Jun 1991 | - | $3.70M |
| Dec 1990 | $8.30M | - |
FAQ
- What is Regeneron Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual total expenses year-on-year change?
- What is Regeneron Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly total expenses year-on-year change?
What is Regeneron Pharmaceuticals annual total expenses?
The current annual total expenses of REGN is $10.11B
What is the all time high annual total expenses for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual total expenses is $10.11B
What is Regeneron Pharmaceuticals annual total expenses year-on-year change?
Over the past year, REGN annual total expenses has changed by +$1.23B (+13.80%)
What is Regeneron Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of REGN is $2.44B
What is the all time high quarterly total expenses for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly total expenses is $2.80B
What is Regeneron Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, REGN quarterly total expenses has changed by +$43.40M (+1.81%)